OMB APPROVAL
  OMB Number:         3235-0167
  UNITED STATES Expires:                    March 31, 2018
 

SECURITIES AND EXCHANGE COMMISSION

  Washington, D.C. 20549

Estimated average burden hours per response                  1.50

   

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number:       000-55016

  

AMARANTUS BIOSCIENCE HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

 

315 Montgomery Street, Suite 900San Francisco, CA 94104 (408) 737-2734

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common

 

(Title of each class of securities covered by this Form)

 

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1)
  Rule 12g-4(a)(2) ☐ 
  Rule 12h-3(b)(1)(i)
  Rule 12h-3(b)(1)(ii) ☐ 
  Rule 15d-6 ☐ 
  Rule 15d-22(b) ☐ 

 

Approximate number of holders of record as of the certification or notice date: 88      

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: 12/4/2017   By: /s/ Gerald E. Commissiong  
        Gerald Commissiong, Chief Executive Officer  

 

Instruction: This form is required by Rules 12g-4, 12h-3 and 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

 

 

Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Amarantus Bioscience (CE) Charts.
Amarantus Bioscience (CE) (USOTC:AMBS)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Amarantus Bioscience (CE) Charts.